BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6425829)

  • 1. Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein.
    Beachey EH; Tartar A; Seyer JM; Chedid L
    Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2203-7. PubMed ID: 6425829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeating covalent structure and protective immunogenicity of native and synthetic polypeptide fragments of type 24 streptococcal M protein. Mapping of protective and nonprotective epitopes with monoclonal antibodies.
    Beachey EH; Seyer JM; Dale JB; Hasty DL
    J Biol Chem; 1983 Nov; 258(21):13250-7. PubMed ID: 6415061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic peptide fragments of streptococcal M proteins.
    Seyer JM; Dale JB; Beachey EH
    Dev Biol Stand; 1986; 63():101-8. PubMed ID: 2427375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein.
    Dale JB; Seyer JM; Beachey EH
    J Exp Med; 1983 Nov; 158(5):1727-32. PubMed ID: 6195292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsonic antibodies evoked by hybrid peptide copies of types 5 and 24 streptococcal M proteins synthesized in tandem.
    Beachey EH; Gras-Masse H; Tarter A; Jolivet M; Audibert F; Chedid L; Seyer JM
    J Exp Med; 1986 Jun; 163(6):1451-8. PubMed ID: 3519829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem.
    Beachey EH; Seyer JM; Dale JB
    J Exp Med; 1987 Sep; 166(3):647-56. PubMed ID: 2442284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein.
    Beachey EH; Seyer JM
    J Immunol; 1986 Mar; 136(6):2287-92. PubMed ID: 2419429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein.
    Kraus W; Haanes-Fritz E; Cleary PP; Seyer JM; Dale JB; Beachey EH
    J Immunol; 1987 Nov; 139(9):3084-90. PubMed ID: 2444650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope specific immunity elicited by a synthetic streptococcal antigen without carrier or adjuvant.
    Jolivet M; Audibert F; Beachey EH; Tartar A; Gras-Masse H; Chedid L
    Biochem Biophys Res Commun; 1983 Dec; 117(2):359-66. PubMed ID: 6197973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vimentin-cross-reactive epitope of type 12 streptococcal M protein.
    Kraus W; Seyer JM; Beachey EH
    Infect Immun; 1989 Aug; 57(8):2457-61. PubMed ID: 2473037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type-specific opsonic antibodies evoked with a synthetic peptide of streptococcal M protein conjugated to polylysine without adjuvant.
    Beachey EH
    Infect Immun; 1986 Jan; 51(1):362-4. PubMed ID: 3941003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence of myosin-crossreactive epitopes of streptococcal M protein.
    Dale JB; Beachey EH
    J Exp Med; 1986 Nov; 164(5):1785-90. PubMed ID: 2430047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein.
    Dale JB; Beachey EH
    J Exp Med; 1986 May; 163(5):1191-202. PubMed ID: 2422314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique and common protective epitopes among different serotypes of group A streptococcal M proteins defined with hybridoma antibodies.
    Dale JB; Beachey EH
    Infect Immun; 1984 Oct; 46(1):267-9. PubMed ID: 6207110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective and heart-crossreactive epitopes located within the NH2 terminus of type 19 streptococcal M protein.
    Bronze MS; Beachey EH; Dale JB
    J Exp Med; 1988 Jun; 167(6):1849-59. PubMed ID: 2455015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective and autoimmune epitopes of streptococcal M proteins.
    Beachey EH; Bronze M; Dale JB; Kraus W; Poirier T; Sargent S
    Vaccine; 1988 Apr; 6(2):192-6. PubMed ID: 3291457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunity evoked by synthetic peptides of streptococcal M proteins.
    Beachey EH
    Adv Exp Med Biol; 1985; 185():193-200. PubMed ID: 2416199
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure-based design of broadly protective group a streptococcal M protein-based vaccines.
    Dale JB; Smeesters PR; Courtney HS; Penfound TA; Hohn CM; Smith JC; Baudry JY
    Vaccine; 2017 Jan; 35(1):19-26. PubMed ID: 27890396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology.
    Hayman WA; Toth I; Flinn N; Scanlon M; Good MF
    Immunol Cell Biol; 2002 Apr; 80(2):178-87. PubMed ID: 11940119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant tetravalent group A streptococcal M protein vaccine.
    Dale JB; Chiang EY; Lederer JW
    J Immunol; 1993 Aug; 151(4):2188-94. PubMed ID: 8345202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.